Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seqirus
Manufacturing
UK enlists CSL Seqirus for flu pandemic vaccine preparedness
The U.K. has struck a deal for CSL Seqirus to manufacture more than 100 million flu vaccines in the case of a pandemic.
Kevin Dunleavy
Sep 26, 2023 10:55am
Japan awarded $115M to Arcturus JV to boost mRNA manufacturing
Aug 14, 2023 11:58am
New CEO Paul McKenzie plots CSL's course for growth
Apr 3, 2023 9:25am
CSL Seqirus to trial avian vaccine candidate in $30M BARDA deal
Oct 10, 2022 10:39am
CSL to unite all business units under one umbrella
Aug 26, 2022 8:12am
Flu vaccine makers gear up for a busy season ahead
Aug 17, 2022 3:05pm